| For: | Xu ZY, Gao JS, He Y, Xiao XQ, Gong GZ, Zhang M. Hepatitis B virus confers innate immunity evasion through hepatitis B virus-miR-3 down-regulation of cGAS-Sting-IFN signaling. World J Hepatol 2025; 17(2): 99292 [PMID: 40027574 DOI: 10.4254/wjh.v17.i2.99292] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i2/99292.htm |
| Number | Citing Articles |
| 1 |
Qiugang Zhu, Yan Yang, Huimin Zhou. Novel insights into the role of cGAS-STING signaling in HBV infection. Virology 2025; 611 doi: 10.1016/j.virol.2025.110639
|
| 2 |
Cao Hua, Saima Aftab, Zulqarnain Baloch. HBV-miR-3 and cGAS-STING axis: a new frontier in hepatitis B therapy. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1662461
|
| 3 |
Zoia R. Korobova, Natalia A. Arsentieva, Anastasia A. Butenko, Oleg K. Batsunov, Natalia E. Lyubimova, Yulia V. Ostankova, Ekaterina V. Anufrieva, Sergey A. Maslov, Konstantin V. Kozlov, Dmitrii L. Sulima, Oksana Yu. Rishnyak, Areg A. Totolian. Disease-Associated Shifts in Minor T Cell Subpopulations Define Distinct Immunopathology in HBV vs. HCV Infection. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26167761
|
| 4 |
Kurt Sartorius, Anna Kramvis, Anil Chuturgoon. MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC. International Journal of Molecular Sciences 2026; 27(17) doi: 10.3390/ijms27177581
|
| 5 |
Hanlin Gao, Zhuoyan Lei, Luye Wang, Yumo Li, Zhi Chen, Gang Wang. The role of HBV in reprogramming liver cancer stem cells and shaping their plasticity and therapeutic vulnerabilities. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05436-9
|
| 6 |
Nida Ansari, Patrick Twohig. Silent sabotage: How hepatitis B virus-miR-3 disarms innate immunity through cGAS-STING suppression. World Journal of Hepatology 2025; 17(6): 106493 doi: 10.4254/wjh.v17.i6.106493
|
| 7 |
Zhengli Tan, Jiayue Shi, Shiyi Zhang, Yanyao Liu. The role of cGAS-STING signaling in the liver and gastrointestinal system: from signaling networks to target intervention. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1682992
|